Skip to main content

Meet the Analyst: Dr. Tara Speranza, Bell Potter Analyst Part 1

Grady Wulff
February 23, 2023

View both parts of the latest episode of our Meet the Analyst series where our Market Analyst, Grady Wulff, sits down with Dr. Tara Speranza, Healthcare & Biotech Analyst at Bell Potter, to discuss her outlook on the stocks she covers, Orthocell (ASX:OCC), Microba Life Sciences (ASX:MAP), and Monash IVF Group (ASX:MVF).

Take a look at Dr. Tara’s journey, her approach to analysing a company, and the first stock to be discussed, Orthocell (ASX:OCC).

In this video, Dr. Tara discusses:
– (0:59) Becoming a Bell Potter Analyst
– (2:56) Approaches to analysing a company
– (7:18) Orthocell’s global 25-year exclusive agreement
– (7:53) Orthocell’s TGA approval for its Remplir device
– (8:44) Orthocell’s speculative buy rating

Note: This interview was filmed on 7 February 2023.

 

View Part 2 here.

Morning Bell 23 January

Bell Direct
January 23, 2023

Weekly Wrap 20 January

Grady Wulff
January 20, 2023

Morning Bell 20 January

Grady Wulff
January 20, 2023

Closing Bell 19 January

Grady Wulff
January 19, 2023

Morning Bell 19 January

Sophia Mavridis
January 19, 2023

Closing Bell 18 January

Grady Wulff
January 18, 2023

Morning Bell 18 January

Grady Wulff
January 18, 2023

Closing Bell 17 January

Grady Wulff
January 17, 2023

Morning Bell 17 January

Sophia Mavridis
January 17, 2023

Closing Bell 16 January

Grady Wulff
January 16, 2023

Morning Bell 16 January

Grady Wulff
January 16, 2023

Thank you and see you in 2023

Grady Wulff
December 20, 2022